We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IX icon
3901
ORIX
IX
$43.9B
$19K ﹤0.01%
+1,205
New +$17K
NVS icon
3902
Novartis
NVS
$288B
$19K ﹤0.01%
200
-4,227
-95% -$369K
OPAD icon
3903
Offerpad Solutions
OPAD
$21.8M
$19K ﹤0.01%
+11
New +$17.7K
LNAI
3904
Lunai Bioworks
LNAI
$10.2M
$19K ﹤0.01%
79
-121
-61% -$30.6K
SCPH
3905
DELISTED
scPharmaceuticals
SCPH
$19K ﹤0.01%
3,540
-2,015
-36% -$15.8K
TITN icon
3906
Titan Machinery
TITN
$420M
$19K ﹤0.01%
952
-22,003
-96% -$377K
VNCE icon
3907
Vince Holding Corp
VNCE
$78.9M
$19K ﹤0.01%
2,930
+1,710
+140% +$9.05K
WINT
3908
DELISTED
Windtree Therapeutics
WINT
0
ZSL icon
3909
ProShares UltraShort Silver
ZSL
$58.6M
$19K ﹤0.01%
+17
New +$22.9K
PHLT
3910
DELISTED
Performant Healthcare Inc
PHLT
$19K ﹤0.01%
21,128
+10,525
+99% +$10.8K
GATO
3911
DELISTED
Gatos Silver, Inc.
GATO
$19K ﹤0.01%
+1,457
New +$11.2K
ERF
3912
DELISTED
Enerplus Corporation
ERF
$19K ﹤0.01%
5,991
-7,913
-57% -$19.2K
MIXT
3913
DELISTED
MIX TELEMATICS LIMITED
MIXT
$19K ﹤0.01%
+1,510
New +$14.9K
CWBR
3914
DELISTED
CohBar, Inc. Common Stock
CWBR
$19K ﹤0.01%
480
-321
-40% -$10.8K
MTCR
3915
DELISTED
Metacrine, Inc. Common Stock
MTCR
$19K ﹤0.01%
+2,457
New +$22.5K
AVCT
3916
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$19K ﹤0.01%
+177
New +$12.7K
CMPI
3917
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$19K ﹤0.01%
1,326
-5,486
-81% -$69.9K
JAX
3918
DELISTED
J. Alexander's Holdings, Inc.
JAX
$19K ﹤0.01%
2,536
+2,054
+426% +$13.1K
MP.WS
3919
DELISTED
MP Materials Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at
MP.WS
$19K ﹤0.01%
+1,251
New +$12.9K
PRVL
3920
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$19K ﹤0.01%
838
-8,630
-91% -$109K
VEDL
3921
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$19K ﹤0.01%
+2,151
New +$14.1K
AMPY icon
3922
Amplify Energy
AMPY
$200M
$18K ﹤0.01%
14,033
+8,559
+156% +$8.49K
ANIK icon
3923
Anika Therapeutics
ANIK
$283M
$18K ﹤0.01%
406
-110
-21% -$4.17K
APRE icon
3924
Aprea Therapeutics
APRE
$8.31M
$18K ﹤0.01%
183
-250
-58% -$119K
AVTX icon
3925
Avalo Therapeutics
AVTX
$1.04B
$18K ﹤0.01%
2
-9
-82% -$62.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.